Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$39.82 USD
+0.67 (1.71%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $39.83 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Tandem Diabetes Care, Inc. [TNDM]
Reports for Purchase
Showing records 141 - 160 ( 241 total )
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Strong Underlying Growth - New Insulin Pump Platform Suggest More Share Gains To Come; Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
American Diabetes Association Meeting Suggests a Diabetes Technology Renaissance Is Coming; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
J-J Medical Devices Investor Day Takeaways on Robotic Surgery, Diabetes, AFib,Sinus Surgery, Endoscopic Stapling
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Volatility in Diabetes Stocks Following UNH/MDT Agreement Creates Buying Opportunity; Reiterate OUTPERFORM on DXCM, PODD, TNDM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Strong performance continues as Q1 beats, guidance raised, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Demand For Tandem''s Insulin Pumps Exceeds Expectations; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Feltl Insulin Pump Project: Historical survey of ~6,000 users
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Medical Devices - Takeaways from J-J''s 1Q16 Results
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Slim with G4 CGM and pipeline bring momentum into 2016, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Q4 2015 Insulin Pump Project: Historical survey of -6,000 users
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Guidance and Margins Much Better Than Expected, Paving a Path Toward Profitability; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Survey of Diabetes Educators Very Positive for DXCM''s Growth Outlook; Suggests Recent Concerns Misplaced; Reiterate OUTPERFORM on DXCM
Provider: WEDBUSH SECURITIES INC.
Company: Tandem Diabetes Care, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Suggests Patients Prefer Tandem''s Insulin Pumps; Reiterate OUTPERFORM on TNDM shares
Provider: WEDBUSH SECURITIES INC.